These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2880575)

  • 1. Interaction of calcium antagonists with beta-adrenoceptor blocking agents.
    Szekeres L; Papp JG
    Arch Toxicol Suppl; 1986; 9():188-96. PubMed ID: 2880575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
    McDevitt DG; Brown HC; Carruthers SG; Shanks RG
    Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the relationship between cardiac beta-adrenoceptor blockade and intrinsic sympathomimetic activity in rats depleted of catecholamines.
    Bilski A; Robertson HH; Wale JL
    Clin Exp Pharmacol Physiol; 1979; 6(1):1-9. PubMed ID: 32980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of propranolol, pindolol, oxprenolol and acebutolol on atrioventricular conduction in unanaesthetized dogs.
    Kantelip JP; Duchene-Marullaz P; Delaigue-Fabry R; Eschalier A
    Br J Clin Pharmacol; 1982; 13(Suppl 2):159S-166S. PubMed ID: 6125165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the stereoisomers of beta-adrenoceptor antagonists in conscious A-V blocked dogs.
    Boucher M; Duchêne-Marullaz P; Moundanga JL
    Br J Pharmacol; 1986 Sep; 89(1):119-27. PubMed ID: 2879587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of three beta-adrenoceptor blocking drugs on isolated preparations of skeletal and cardiac muscle.
    Harry JD; Linden RJ; Snow HM
    Br J Pharmacol; 1974 Oct; 52(2):275-81. PubMed ID: 4155991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the electropharmacological effects of verapamil and propranolol in the halothane-anesthetized in vivo canine model under monophasic action potential monitoring.
    Shiina H; Sugiyama A; Takahara A; Satoh Y; Hashimoto K
    Jpn Circ J; 2000 Oct; 64(10):777-82. PubMed ID: 11059619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic sympathomimetic activity and the effects of beta-adrenergic blocking drugs on vulnerability to ventricular fibrillation.
    Raeder EA; Verrier RL; Lown B
    J Am Coll Cardiol; 1983 Jun; 1(6):1442-6. PubMed ID: 6133890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between two calcium antagonists and two beta blockers in conscious rabbits: hemodynamic consequences of differing cardiodepressant properties.
    Hof RP
    Am J Cardiol; 1987 Jan; 59(3):43B-51B. PubMed ID: 2880495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenoceptor blockade and atrio-ventricular conduction in dogs. Role of intrinsic sympathomimetic activity.
    Giudicelli JF; Lhoste F
    Br J Clin Pharmacol; 1982; 13(Suppl 2):167S-174S. PubMed ID: 6125166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sympathomimetic and cardiodepressant effects of acebutolol, oxprenolol, pindolol, and propranolol. A comparative study on changes in hemodynamics, contractility, heart rate, and AV-conduction time at therapeutic doses.
    Gülker H; Kristek J; Heuer H; Bender F
    Arzneimittelforschung; 1981; 31(9):1416-22. PubMed ID: 6118162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reflex chronotropic and inotropic effects of calcium channel-blocking agents in conscious dogs. Diltiazem, verapamil, and nifedipine compared.
    Nakaya H; Schwartz A; Millard RW
    Circ Res; 1983 Mar; 52(3):302-11. PubMed ID: 6825222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of beta-adrenoceptor blocking drugs in hyperthyroidism.
    Feely J; Peden N
    Drugs; 1984 May; 27(5):425-46. PubMed ID: 6144501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulant and depressant effects of beta-adrenoceptor blocking agents on isolated heart muscle. A positive inotropic effect not mediated through andrenoceptors.
    Kaumann AJ; Blinks JR
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Apr; 311(3):205-18. PubMed ID: 6104791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time course and extent of alpha 1-adrenoceptor density changes in rat heart after beta-adrenoceptor blockade.
    Steinkraus V; Nose M; Scholz H; Thormählen K
    Br J Pharmacol; 1989 Feb; 96(2):441-9. PubMed ID: 2564293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of beta-adrenoceptor blocking agents, with differing ancillary properties, on the arrhythmias resulting from acute coronary artery ligation in anaesthetized rats.
    Campbell CA; Parratt JR
    Br J Pharmacol; 1983 Aug; 79(4):939-46. PubMed ID: 6140049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium ions, drug action and the heart--with special reference to calcium antagonist drugs.
    Opie LH
    Pharmacol Ther; 1984; 25(3):271-95. PubMed ID: 6151199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.
    Farmer JB; Kennedy I; Levy GP; Marshall RJ
    Br J Pharmacol; 1972 Aug; 45(4):660-75. PubMed ID: 4404413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium-antagonist effects of norbormide on isolated perfused heart and cardiac myocytes of guinea-pig: a comparison with verapamil.
    Bova S; Cargnelli G; D'Amato E; Forti S; Yang Q; Trevisi L; Debetto P; Cima L; Luciani S; Padrini R
    Br J Pharmacol; 1997 Jan; 120(1):19-24. PubMed ID: 9117093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.